Researchers assessed the attainment of traditional cardiovascular risk factor therapeutic goals in patients with antiphospholipid syndrome vs those with rheumatoid arthritis and diabetes mellitus.
Researchers assessed the effect of patients’ psychosocial characteristics on disease activity and remission during the early course of rheumatoid arthritis.
The researchers detected US subclinical synovitis in one or more scans in 77.3 percent of 97 progressors (median time from first evidence of US synovitis to inflammatory arthritis development, 26.5 weeks).
Researchers evaluated the management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis receiving tofacitinib treatment.
Researchers studied the inhibition of progression of structural joint damage in patients with moderate to severe active rheumatoid arthritis who were receiving upadacitinib.
Machine learning integrating clinical and genomic data can be used to predict methotrexate treatment response in early rheumatoid arthritis.
Researchers assessed interest levels and factors associated with interest among first-degree relatives of patients with rheumatoid arthritis.
A serum protein biomarker panel can differentiate patients with early inflammatory arthritis with psoriatic arthritis from those with rheumatoid arthritis.
Researchers assessed the characteristics, comorbidities, and outcomes of SARS-CoV-2 infection in patients with rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis who were receiving systemic therapies.
Researchers determined the link between patient-reported outcome measure scores and organ damage in patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis.
